• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00570630
Medical Device Problem Code Positioning Problem (3009)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/25/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Block h6: imdrf device code a1502 captures the reportable event of stent positioning issue.
 
Event or Problem Description
It was reported to boston scientific corporation that a wallflex biliary rx uncovered stent was to be implanted in the common bile duct to treat a 6mm cholangiocarcinoma during an endoscopic retrograde biliary drainage (erbd) with stent placement procedure performed on (b)(6) 2024.The patient's anatomy was not tortuous and was not dilated prior to stent placement.During the procedure, the stent could not be reconstrained before the marker reached the non-return point.Subsequently, the stent was deployed and was removed using forceps.The procedure was completed with another wallflex biliary of a different size.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Additional Manufacturer Narrative
Block h6: imdrf device code a1502 captures the reportable event of stent positioning issue.Block h11: a wallflex biliary uncovered stent and delivery system were received for analysis.The stent was received fully deployed and expanded.No problems were noted with the stent and delivery system.The reported event of stent positioning issue could not be confirmed because this event occurred during the procedure, and the stent was returned fully deployed and expanded.However, the reported event is noted within the manufacturer's labeling as a potential adverse event associated with the use of this device.Therefore, a review and analysis of all available information indicated the most probable cause is known inherent risk of device.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.
 
Event or Problem Description
It was reported to boston scientific corporation that a wallflex biliary rx uncovered stent was to be implanted in the common bile duct to treat a 6mm cholangiocarcinoma during an endoscopic retrograde biliary drainage (erbd) with stent placement procedure performed on (b)(6) 2024.The patient's anatomy was not tortuous and was not dilated prior to stent placement.During the procedure, the stent could not be reconstrained before the marker reached the non-return point.Subsequently, the stent was deployed and was removed using forceps.The procedure was completed with another wallflex biliary of a different size.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key19365078
Report Number3005099803-2024-02292
Device Sequence Number15038482
Product Code FGE
UDI-Device Identifier08714729759270
UDI-Public08714729759270
Combination Product (Y/N)N
Initial Reporter CountryTW
PMA/510(K) Number
K140630
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/24/2025
Device Model NumberM00570630
Device Catalogue Number7063
Device Lot Number0032081210
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/25/2024
Supplement Date Received by Manufacturer07/09/2024
Initial Report FDA Received Date05/21/2024
Supplement Report FDA Received Date08/06/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/25/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
Patient SexFemale
-
-